Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ruimin Hao
China National Medical Products Administration Approval Summary: Anlotinib for the Treatment of Advanced Non-Small Cell Lung Cancer After Two Lines of Chemotherapy
Cancer Communications
Cancer Research
Oncology
Related publications
Approval Summary: Pemetrexed Maintenance Therapy of Advanced/Metastatic Nonsquamous, Non-Small Cell Lung Cancer (NSCLC)
Oncologist
Cancer Research
Medicine
Oncology
Palliative Chemotherapy for Advanced Non-Small Cell Lung Cancer
BMJ
A Case of Multiple Transient Ischemic Attacks After Chemotherapy for Advanced Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Targeted Therapy for the Treatment of Advanced Non-Small Cell Lung Cancer
Chest
Cardiology
Critical Care
Cardiovascular Medicine
Intensive Care Medicine
Pulmonary
Respiratory Medicine
Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma
Afatinib Treatment in Advanced Non-Small Cell Lung Cancer
Lung Cancer: Targets and Therapy
Oncology
Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer
Japanese Journal of Lung Cancer
Oncology
Respiratory Medicine
Pulmonary
Treatment Results Including More Than Third-Line Chemotherapy for Patients With Advanced Non-Small Cell Lung Cancer
Oncology Letters
Cancer Research
Oncology
P1.03-16 Anlotinib Inhibits Angiogenesis of Refractory Advanced Non-Small Cell Lung Cancer via Blocking CCL2 Expression
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
